These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2120811)

  • 1. Enhancement of T cell-depleted bone marrow allografts in mice by thiotepa.
    Terenzi A; Lubin I; Lapidot T; Salomon O; Faktorowich Y; Rabi I; Martelli MF; Reisner Y
    Transplantation; 1990 Oct; 50(4):717-20. PubMed ID: 2120811
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases.
    Rosales F; Peylan-Ramu N; Cividalli G; Varadi G; Or R; Naparstek E; Slavin S; Nagler A
    Bone Marrow Transplant; 1999 May; 23(9):861-5. PubMed ID: 10338039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Booster irradiation to the spleen following total body irradiation. A new immunosuppressive approach for allogeneic bone marrow transplantation.
    Lapidot T; Singer TS; Salomon O; Terenzi A; Schwartz E; Reisner Y
    J Immunol; 1988 Oct; 141(8):2619-24. PubMed ID: 3049814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
    Soderling CC; Song CW; Blazar BR; Vallera DA
    J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient engraftment of T cell-depleted allogeneic bone marrow in mice improves survival rate following lethal irradiation.
    Lapidot T; Singer TS; Reisner Y
    Bone Marrow Transplant; 1988 Mar; 3(2):157-64. PubMed ID: 3048480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice.
    Down JD; Westerhof GR; Boudewijn A; Setroikromo R; Ploemacher RE
    Bone Marrow Transplant; 1998 Feb; 21(4):327-30. PubMed ID: 9509964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of strong classic immune reactivity after total-body irradiation for bone marrow transplantation. Implications for human T-depleted bone marrow transplantation.
    Gassmann W; von Kolszynski M; Wottge HU; Müller-Ruchholtz W
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2687-8. PubMed ID: 3079091
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of fludarabine as an immunosuppressor for bone marrow transplantation conditioning: preliminary results.
    Terenzi A; Aristei C; Aversa F; Perruccio K; Chionne F; Raymondi C; Latini P; Martelli MF
    Transplant Proc; 1996 Dec; 28(6):3101. PubMed ID: 8962201
    [No Abstract]   [Full Text] [Related]  

  • 11. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P
    Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohematopoietic reconstitution by allogeneic and autologous bone marrow grafts as a means for induction of specific unresponsiveness to donor-specific allografts and modified self in autoimmune disorders.
    Slavin S; Karussis D; Weiss L; Vourka-Karussis U; Abramsky O
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1274-5. PubMed ID: 8442110
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of BM allografting from C57BL/6 'nude' mice into C3H/HeJ recipients by tolerized T cells from (C57BL/6-->C3H/HeJ) and (C3H/HeJ-->C57BL/6) chimeras.
    Faktorowich Y; Lapidot T; Lubin I; Reisner Y
    Bone Marrow Transplant; 1993 Jul; 12(1):15-20. PubMed ID: 8374532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
    Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
    Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nondeletional mechanisms of tolerance in total-lymphoid irradiation-induced bone marrow chimeras.
    Field EH; Steinmuller D
    Transplantation; 1993 Jul; 56(1):250-3. PubMed ID: 8333061
    [No Abstract]   [Full Text] [Related]  

  • 17. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
    Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
    J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation with T-cell depleted allografts for the treatment of severe beta thalassemia major.
    Or R; Naparstek E; Aker M; Cividalli G; Engelhard D; Brautbar C; Weshler Z; Weiss L; Mumcuoglu M; Rachmilewitz EA
    Prog Clin Biol Res; 1989; 309():217-22. PubMed ID: 2675089
    [No Abstract]   [Full Text] [Related]  

  • 19. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired B-cell tolerance in complete as compared with mixed chimeras after allogeneic bone marrow transplantation.
    Waer M; Salam A; Vandeputte M
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1281-2. PubMed ID: 8442112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.